ACTUATE THERAPEUTICS INC (ACTU) Forecast, Price Target & Analyst Ratings

NASDAQ:ACTU • US0050831009

Current stock price

2.29 USD
+0.14 (+6.51%)
At close:
2.29 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ACTUATE THERAPEUTICS INC (ACTU).

Forecast Snapshot

Consensus Price Target

Price Target
$25.50
+ 1,013.54% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 15, 2026
Period
Q4 / 2025
EPS Estimate
-$0.25
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$25.50
Upside
+ 1,013.54%
From current price of $2.29 to mean target of $25.50, Based on 10 analyst forecasts
Low
$20.20
Median
$22.95
High
$36.75

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for ACTU. The average price target is 25.5 USD. This implies a price increase of 1013.54% is expected in the next year compared to the current price of 2.29.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ACTU Current Analyst RatingACTU Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ACTU Historical Analyst RatingsACTU Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.00%
ACTU was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about ACTU.
In the previous month the buy percentage consensus was at a similar level.
ACTU was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-11-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-23HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-26B. Riley SecuritiesInitiate Buy
2025-08-18HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-17HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 15, 2026
Period
Q4 / 2025
EPS Estimate
-$0.25
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
24.27%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

ACTU is expected to report earnings on 5/15/2026. The consensus EPS estimate for the next earnings is -0.25 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ACTU revenue by date.ACTU revenue by date.
N/AN/AN/AN/A
354.01%		N/A
388.33%		N/A
86.66%		N/A
57.39%		N/A
37.98%		N/A
28.91%
EBITDA
YoY % growth
ACTU ebitda by date.ACTU ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ACTU ebit by date.ACTU ebit by date.
-20.207M-24.974M
-23.59%		-25.161M
-0.75%		N/A
5.05%		N/A
-21.23%		N/A
-48.28%		N/A
-8.41%		N/A
118.17%		N/A
973.92%		N/A
91.97%		N/A
49.94%		N/A
35.14%
Operating Margin
ACTU operating margin by date.ACTU operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ACTU eps by date.ACTU eps by date.
N/AN/AN/AN/A
65.51%		N/A
4.36%		N/A
-35.49%		N/A
6.78%		N/A
116.14%		N/A
798.82%		N/A
79.06%		N/A
12.57%		N/A
19.48%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.25
24.27%		-0.26
20.31%		-0.22
27.61%		-0.24
4.12%		-0.26
-2.04%		-0.30
-16.00%		-0.34
-50.00%		-0.37
-53.19%		-0.40
-56.00%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-5.729M
12.65%		-6.375M
-0.15%		-7.14M
-19.62%		-7.65M
-39.79%		-8.415M
-46.88%		-10.2M
-60.00%		-11.475M
-60.71%		-12.75M
-66.67%		-14.025M
-66.67%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ACTU Yearly Revenue VS EstimatesACTU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
ACTU Yearly EPS VS EstimatesACTU Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
15.80%
EPS Next 5 Year
15.63%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ACTUATE THERAPEUTICS INC / ACTU Forecast FAQ

Can you provide the average price target for ACTUATE THERAPEUTICS INC stock?

10 analysts have analysed ACTU and the average price target is 25.5 USD. This implies a price increase of 1013.54% is expected in the next year compared to the current price of 2.29.

When does ACTUATE THERAPEUTICS INC (ACTU) report earnings?

ACTUATE THERAPEUTICS INC (ACTU) will report earnings on 2026-05-15.

What are the consensus estimates for ACTU stock next earnings?

The consensus EPS estimate for the next earnings of ACTUATE THERAPEUTICS INC (ACTU) is -0.25 USD and the consensus revenue estimate is 0 USD.